VGLSD VG Life Sciences Inc.
Fundamentals / CIK 0001091326 / USDVG Life Sciences Inc. reported $0 in revenue and a net loss of $4.30M for the trailing twelve months ended September 30, 2015.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VGLSD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2015
-
Operating Income TTM-$2.73M Operating profit
-
Net Income TTM-$4.30M GAAP bottom line
-
Diluted EPS TTM-$0.05 Split-adjusted
-
Free Cash Flow TTM-$1.91M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2015$23K Total debt: --
Annual revenue and net income
2 fiscal years (2013 to 2014), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Revenue | $0 | $0 |
| Research & Development | $866K | $809K |
| Operating Income | -$4.14M | -$3.91M |
| EBITDA | -$4.14M | -$3.91M |
| Interest Expense | $2.76M | $1.08M |
| Income Tax Expense | $0 | $0 |
| Net Income | -$6.19M | -$7.42M |
| Basic EPS | -$0.22 | -$0.91 |
| Diluted EPS | -$0.22 | -$0.91 |
| Basic Shares Outstanding | 27.6M | 8.2M |
| Diluted Shares Outstanding | 27.6M | 8.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $140K | $163K | $160K | -$110K | $340K | $224K | $412K | $300K |
| Operating Income | -$644K | -$739K | -$801K | -$541K | -$799K | -$1.15M | -$1.65M | -$854K |
| EBITDA | -- | -- | -- | -- | -$799K | -- | -- | -$854K |
| Interest Expense | $250K | $432K | $715K | $666K | $688K | $554K | $852K | $72K |
| Net Income | -$1.01M | -$1.40M | -$1.46M | -$424K | -$1.06M | -$2.00M | -$2.70M | -$1.55M |
| Basic EPS | -$0.01 | -$0.02 | -$0.03 | -- | -$0.04 | -$0.09 | -$0.14 | -$0.18 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.03 | -- | -$0.04 | -$0.09 | -$0.14 | -$0.18 |
| Basic Shares Outstanding | 85.5M | 66.9M | 51.6M | -- | 28.9M | 22.8M | 18.9M | 8.4M |
| Diluted Shares Outstanding | 85.5M | 66.9M | 51.6M | -- | 28.9M | 22.8M | 18.9M | 8.4M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $34K | $714K |
| Cash & Short-Term Investments | $34K | $714K |
| Total Current Assets | $246K | $789K |
| Property, Plant & Equipment, Net | $0 | $0 |
| Intangible Assets | $1.08M | $1.08M |
| Total Non-Current Assets | $1.08M | $1.08M |
| Total Assets | $1.32M | $1.87M |
| Accounts Payable | $710K | $405K |
| Total Current Liabilities | $5.83M | $6.33M |
| Total Non-Current Liabilities | $0 | $0 |
| Total Liabilities | $5.83M | $6.33M |
| Common Stock | $4.6K | $1.7K |
| Retained Earnings | -$106.0M | -$99.78M |
| Total Stockholders' Equity | -$4.51M | -$4.47M |
| Total Equity | -$4.51M | -$4.47M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2013-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $23K | $4.3K | $30K | $34K | $54K | $714K |
| Cash & Short-Term Investments | $23K | $4.3K | $30K | $34K | $54K | $714K |
| Total Current Assets | $40K | $39K | $92K | $246K | $60K | $789K |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M |
| Total Non-Current Assets | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M |
| Total Assets | $1.12M | $1.12M | $1.17M | $1.32M | $1.14M | $1.87M |
| Accounts Payable | $837K | $726K | $685K | $710K | $866K | $405K |
| Total Current Liabilities | $5.46M | $5.96M | $5.89M | $5.83M | $6.31M | $6.33M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.46M | $5.96M | $5.89M | $5.83M | $6.31M | $6.33M |
| Common Stock | $10K | $7.7K | $6.1K | $4.6K | $3.1K | $1.7K |
| Retained Earnings | -$109.8M | -$108.8M | -$107.4M | -$106.0M | -$105.5M | -$99.78M |
| Total Stockholders' Equity | -$4.34M | -$4.84M | -$4.73M | -$4.51M | -$5.17M | -$4.47M |
| Total Equity | -$4.34M | -$4.84M | -$4.73M | -$4.51M | -$5.17M | -$4.47M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$6.22M | -$7.48M |
| Depreciation & Amortization | $0 | $0 |
| Stock-Based Compensation | $0 | $0 |
| Change in Payables | $317K | $75K |
| Operating Cash Flow | -$1.91M | -$1.04M |
| Capital Expenditure | $0 | $0 |
| Free Cash Flow | -$1.91M | -$1.04M |
| Investing Cash Flow | $0 | $0 |
| Common Stock Issued | $0 | $0 |
| Financing Cash Flow | $1.23M | $1.75M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.02M | -$1.41M | -$1.47M | -$433K | -$1.07M | -$2.01M | -$2.71M | -$1.56M |
| Depreciation & Amortization | -- | -- | -- | -- | $0 | -- | -- | $0 |
| Stock-Based Compensation | $63K | $86K | $92K | -- | -- | -- | -- | -- |
| Change in Payables | $115K | $41K | $12 | -$145K | $2.8K | $202K | $256K | -- |
| Operating Cash Flow | -$48K | -$238K | -$165K | -$407K | -$468K | -$309K | -$725K | -- |
| Financing Cash Flow | $67K | $212K | $161K | $388K | $489K | $193K | $160K | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Assets (ROA) | -467.8% | -397.6% |
| Current Ratio | 0.04x | 0.12x |
| Quick Ratio | 0.01x | 0.11x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -384.8% | -389.6% | -423.3% | -467.8% | -- | -- | -- | -- |
| Current Ratio | 0.01x | 0.01x | 0.02x | 0.04x | 0.01x | -- | -- | -- |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | -- | -- | -- |